We were one of 34 organisations to sign an open letter addressed to European Commission President-elect Jean-Claude Juncker.

This action was in response to the decision to move the competence for medicinal products and health technologies from the Commissioner in charge of health to the Commissioner in charge of internal market and industry in the incoming Commission.